The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

The aggregate gross proceeds to Benitec from the underwritten offering and the concurrent registered direct offering are expected to be approximately $30 million, prior to deducting underwriting ...

This infographic explores the role of gene therapy in treating haemophilia, focusing specifically on haemophilia A and B. It ...

Nearly two-thirds of workplace bullies are bosses, according to the Workplace Bullying Institute. Here's what companies ...

The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...

The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...

Researchers with Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real ...

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.

Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

Studies conducted in human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) compared various cassette configurations and informed the final design of TN-201, which incorporates a ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

Is immortality achievable? With longevity science booming, you might make it to age 150. We separate the hype from proven ...